Weekly Digest

May 5, 2026

Volume 2, Issue 1

 

Health Subcommittee Holds Hearing on FDA Food and Supplement Bills

The House Energy and Commerce Subcommittee on Health held a legislative hearing titled “Healthier America: Legislative Proposals on the Regulation and Oversight of Food,” reviewing a slate of bills affecting FDA’s authority over foods, ingredients, and dietary supplements. The hearing examined proposals on safety determinations, labeling, and federal versus state oversight. Industry groups, including CRN and NPA, used the moment to press for regulatory modernization that preserves DSHEA’s framework.

Rep. Langworthy Reaffirms Push for Dietary Supplement Regulatory Uniformity Act

At the April 29 House subcommittee hearing, Rep. Nick Langworthy (R-NY) reaffirmed his support for H.R. 7366, the Dietary Supplement Regulatory Uniformity Act, which he introduced on February 4. Langworthy argued that for nearly 30 years, dietary supplements have been regulated under a single, science-based national framework led by the FDA, and that a growing patchwork of state laws threatens DSHEA’s core uniformity. The bill would reaffirm FDA as the sole national regulator for dietary supplements.

 

Supplement Industry Unites Around Innovation-Forward Interpretation of “Dietary Substance”

The supplement industry has flooded the FDA’s docket with nearly 1,000 comments, urging the agency to abandon its longstanding “commonly used as food” test for dietary ingredients. CRN, AHPA, NPA, and other trade groups argue Section 201(ff)(1)(E) of DSHEA was always intended as a forward-looking, innovation-friendly category that recognizes substances produced through synthesis, cell culture, and precision fermentation. The comments mark a critical moment in FDA’s effort to modernize how DSHEA applies to the next generation of supplement ingredients.

Nature’s Truth to Revise Magnesium Claims After NAD Ruling

BBB National Programs’ National Advertising Division recommended that Nature’s Truth modify or discontinue front-of-package claims of “200 mg magnesium per serving” on its magnesium glycinate gummies, after a Pharmavite challenge highlighted that the supplement facts panel listed only 22 mg of elemental magnesium. NAD found the claim “literally true” but misleading, a precedent with broad implications for self-regulation of supplement labeling. Nature’s Truth said it will comply, signaling continued vigor for industry self-policing as FDA looks to streamline DSHEA disclaimer rules.

 

India Bans Ashwagandha Leaf Use in Any Form, Industry Reacts

Following directives from India’s Ministry of Ayush and FSSAI, ashwagandha leaves are now prohibited in any form across food, nutraceutical, and Ayush products, with regulators citing higher concentrations of withaferin-A in aerial plant parts compared to roots. The ruling will require U.S. supplement brands relying on Indian sources to verify root-only sourcing and update labels disclosing the plant part used. The action illustrates how foreign regulatory shifts can directly affect ingredient supply chains for DSHEA-regulated products in the United States.

 

Vitamin D Boosts Breast Cancer Treatment Success by 79%

A clinical trial from the Botucatu School of Medicine at São Paulo State University found that women receiving 2,000 IU of vitamin D daily during neoadjuvant chemotherapy were nearly twice as likely to see complete tumor disappearance, with 43% of vitamin D recipients achieving complete response versus 24% in the placebo group. The 80-patient trial supports a growing body of evidence on vitamin D’s adjunctive role in cancer care. Findings reinforce supplement makers’ message that DSHEA-regulated nutrients can play a meaningful, science-backed role in health outcomes.

Scientists Reveal Creatine’s Hidden Power Beyond Muscle Gains

New research highlights creatine’s expanding role beyond athletics, showing it may support memory, mood, and cognitive speed, particularly in people with lower baseline levels. The findings are accelerating creatine’s adoption among older adults, women, and Gen Z consumers, segments now driving double-digit category growth. As creatine moves from sports nutrition into the cognitive health and longevity aisle, manufacturers will need to navigate structure-function claim limits under DSHEA carefully.

GLP-1 Side Effects Fuel a Booming Hair and Nutrition Supplement Market

Retailers and supplement brands are racing to address hair thinning, nutrient deficiency, and lean-mass loss reported by GLP-1 users, with Ulta, Redken, and a wave of supplement makers launching new lines targeted to this consumer base. Protein, fiber, hydration formulas, and biotin-based hair products are leading the surge. The trend represents one of the largest organic growth opportunities for DSHEA-regulated products in years, even as regulators watch closely for impermissible disease claims.

 

April Launch Pad: Personalized Wellness, Ingestible Beauty, and Gut Health

April brought a wave of new launches centered on personalized wellness, ingestible beauty, and gut health, with Shaklee debuting Liquid BioCell Life+ for whole-body longevity, Sifts introducing a chitosan-and-prebiotic formula targeting microplastic exposure, and k2o by Sprinter blending electrolytes with collagen peptides. The releases reflect how brands are layering innovative ingredients onto familiar DSHEA categories. Each launch underscores why FDA’s “dietary substance” definition matters so much for the next wave of supplement innovation.

 

DSHEA Preservation Alliance

DSHEA.org
  |  
About
  |  
Issues
  |  
Media & Newsroom

You are receiving this email because you subscribed to the DSHEA Weekly Digest.
Unsubscribe
 · 
Update preferences

Powered by PICXM